Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1985;71:797-804

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dibner-Dunlap, M. E.
Right arrow Articles by Cintron-Trevino, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dibner-Dunlap, M. E.
Right arrow Articles by Cintron-Trevino, N. M.

Circulation, Vol 71, 797-804, Copyright © 1985 by American Heart Association


ARTICLES

The long-term increase of baseline and reflexly augmented levels of human vagal-cardiac nervous activity induced by scopolamine

ME Dibner-Dunlap, DL Eckberg, NM Magid and NM Cintron-Trevino

We tested the hypothesis that transdermal scopolamine increases vagal- cardiac nervous outflow over the long term in 16 healthy young men. Twenty-four hours after application of one scopolamine patch, the average RR interval was increased by 13% and the average standard deviation of the RR interval (taken as an index of the level of vagal- cardiac nervous activity) was increased by 31%. Baroreceptor-cardiac reflex responsiveness (as reflected by prolongation of RR interval provoked by graded neck suction) also was increased substantially. These findings suggest that vagal-cardiac nervous activity can be augmented pharmacologically in man on a long-term basis. Since vagal outflow influences cardiac electrical properties in an important way, these findings may have therapeutic implications.


This article has been cited by other articles:


Home page
HeartHome page
R R T Castro, G Porphirio, S M Serra, and A C L Nobrega
Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia
Heart, October 1, 2004; 90(10): 1119 - 1123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Bibevski and M. E. Dunlap
Prevention of diminished parasympathetic control of the heart in experimental heart failure
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1780 - H1785.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. E. Dunlap, S. Bibevski, T. L. Rosenberry, and P. Ernsberger
Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1632 - H1640.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Montano, C. Cogliati, A. Porta, M. Pagani, A. Malliani, K. Narkiewicz, F. M. Abboud, C. Birkett, and V. K. Somers
Central Vagotonic Effects of Atropine Modulate Spectral Oscillations of Sympathetic Nerve Activity
Circulation, October 6, 1998; 98(14): 1394 - 1399.
[Abstract] [Full Text] [PDF]